| Literature DB >> 26308020 |
Hao Yin1,2, Linyu Xu3, Yanpeng Cai4,5.
Abstract
Severe health risks caused by PM10 (particulate matter with an aerodynamic diameter ≤10 μm) pollution have induced inevitable economic losses and have rendered pressure on the sustainable development of society as a whole. In China, with the "Polluters Pay Principle", polluters should pay for the pollution they have caused, but how much they should pay remains an intractable problem for policy makers. This paper integrated an epidemiological exposure-response model with economics methods, including the Amended Human Capital (AHC) approach and the Cost of Illness (COI) method, to value the economic loss of PM10-related health risks in 16 districts and also 4 functional zones in Beijing from 2008 to 2012. The results show that from 2008 to 2012 the estimated annual deaths caused by PM10 in Beijing are around 56,000, 58,000, 63,000, 61,000 and 59,000, respectively, while the economic losses related to health damage increased from around 23 to 31 billion dollars that PM10 polluters should pay for pollution victims between 2008 and 2012. It is illustrated that not only PM10 concentration but also many other social economic factors influence PM10-related health economic losses, which makes health economic losses show a time lag discrepancy compared with the decline of PM10 concentration. In conclusion, health economic loss evaluation is imperative in the pollution indemnity system establishment and should be considered for the urban planning and policy making to control the burgeoning PM10 health economic loss.Entities:
Keywords: Beijing; health loss; health risk; inhalable particulate matter (PM10); monetary valuation
Mesh:
Substances:
Year: 2015 PMID: 26308020 PMCID: PMC4555323 DOI: 10.3390/ijerph120809967
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Different economic analysis methods and their characteristics.
| Economic Evaluation Method | Advantages | Limitation | Scope of Application |
|---|---|---|---|
| AHC | It can obtain data conveniently; It is simple and clear; it is time-saving and economic for researchers; It reflects human health economic loss in a certain degree. | It cannot reflect the medical costs due to the disease. | It is suited to the chronic diseases that cause absence from work; It is suitable for deaths caused by diseases. |
| COI | Includes all costs caused by certain diseases, direct medical costs, the direct nonmedical costs and indirect costs reflect the human health loss. | It is limited to short-term health impacts costs estimation. | It is suitable for acute diseases that can be obtained in hospitals. |
Figure 1Functional regionalization of Beijing.
PM10 related health impacts exposure-response coefficients β.
| Health Endpoints | β (95% CI) | E0 |
|---|---|---|
| Individual mortality | 4.3 (2.60, 6.10) [ | 0.01013 [ |
| Chronic bronchitis | 5.77 (1.93, 9.61) [ | 0.01390 [ |
| Respiratory hospitalization | 1.2 (0.80, 1.60) [ | 0.01022 [ |
| Cardiovascular hospitalization | 0.7 (0.30, 1.10) [ | 0.00546 [ |
| Outpatient visits to internal medicine | 0.01374 (0.01077, 0.01679) [ | 0.41105 [ |
| Outpatient visits to pediatrics | 0.01551 (0.01041, 0.02060) [ | 0.15300 [ |
| Acute bronchitis | 5.5 (1.89, 9.11) [ | 0.03800 [ |
| Asthma attacks | 3.9 (1.90, 5.90) [ | 0.05610 [ |
Estimated medical costs per case of different health endpoints.
| Year | Medical Costs ($) | |||
|---|---|---|---|---|
| Hospitalization | Asthma Attacks | Acute Bronchitis | Outpatient Visits | |
| 2008 | 2233.94 | 255.54 | 406.77 | 52.41 |
| 2009 | 2595.36 | 293.67 | 434.19 | 54.88 |
| 2010 | 2650.59 | 319.90 | 463.47 | 57.35 |
| 2011 | 2705.81 | 346.13 | 494.72 | 59.82 |
| 2012 | 2761.04 | 372.36 | 528.08 | 59.82 |
Figure 2Annual PM10 concentration and population of different districts and counties in Beijing from 2009 to 2012.
PM10-related health risks from 2008 to 2012.
| Health Endpoints | Frequencies (95% CI) | ||||
|---|---|---|---|---|---|
| 2008 | 2009 | 2010 | 2011 | 2012 | |
| Individual mortality | 0.0093 (0.0082–0.0105) | 0.0093 (0.0081–0.0104) | 0.0093 (0.0081–0.0104) | 0.0091 (0.0080–0.0101) | 0.0089 (0.0079–0.0100) |
| Chronic bronchitis | 0.0203 (0.0157–0.0249) | 0.0202 (0.0157–0.0248) | 0.0202 (0.0157–0.0248) | 0.0198 (0.0156–0.0240) | 0.0195 (0.0155–0.0235) |
| Respiratory hospitalization | 0.0115 (0.0111–0.0119) | 0.0115 (0.0110–0.0119) | 0.0115 (0.0110–0.0119) | 0.0114 (0.0110–0.0118) | 0.0113 (0.0109–0.0117) |
| Cardiovascular hospitalization | 0.0059 (0.0056–0.0061) | 0.0058 (0.0056–0.0061) | 0.0058 (0.0056–0.0061) | 0.0058 (0.0056–0.0060) | 0.0058 (0.0056–0.0060) |
| Outpatient visits to internal medicine | 0.4116 (0.4115–0.4118) | 0.4116 (0.4115–0.4117) | 0.4116 (0.4115–0.4116) | 0.4116 (0.4115–0.4117) | 0.4116 (0.4114–0.4117) |
| Outpatient visits to pediatrics | 0.1532 (0.1532–0.1533) | 0.1532 (0.1532–0.1533) | 0.1532 (0.1532–0.1533) | 0.1532 (0.1531–0.1533) | 0.1532 (0.1531–0.1533) |
| Acute bronchitis | 0.0593 (0.0453–0.0733) | 0.0591 (0.0453–0.0730) | 0.0591 (0.0453–0.0730) | 0.0576 (0.0448–0.0705) | 0.0566 (0.0444–0.0688) |
| Asthma attacks | 0.0784 (0.0670–0.0899) | 0.0782 (0.0669–0.0895) | 0.0782 (0.0669–0.0895) | 0.0767 (0.0661–0.0872) | 0.0756 (0.0656–0.0856) |
PM10-related health impacts from 2008 to 2012.
| Health Endpoints | Number of Cases | ||||
|---|---|---|---|---|---|
| 2008 | 2009 | 2010 | 2011 | 2012 | |
| Individual mortality | 55,844 | 57,196 | 63,910 | 60,800 | 58,675 |
| Chronic bronchitis | 126,528 | 129,592 | 144,803 | 137,745 | 132,921 |
| Respiratory hospitalization | 22,400 | 22,954 | 25,648 | 24,493 | 23,706 |
| Cardiovascular hospitalization | 6833 | 7003 | 7825 | 7482 | 7248 |
| Outpatient visits to internal medicine | 9771 | 10,018 | 11,194 | 10,726 | 10,406 |
| Outpatient visits to pediatrics | 4106 | 4210 | 4704 | 4507 | 4373 |
| Acute bronchitis | 431,698 | 442,139 | 494,037 | 469,848 | 453,285 |
| Asthma attacks | 436,235 | 446,815 | 499,261 | 475,068 | 458,547 |
| All | 1,093,415 | 1,119,927 | 1,251,383 | 1,190,669 | 1,149,161 |
Figure 3Health impacts of different districts and counties.
Figure 4Different health impacts in different districts and counties in 2010. Note: In Figure 4, IM, CB, RH, CH, OIM, OP, AB and asthma attacks refer to individual mortality, chronic bronchitis, respiratory hospitalization, cardiovascular hospitalization, outpatient visits to internal medicine, outpatient visits to pediatrics, acute bronchitis, asthma attacks, respectively. The size of the pie chart refers to the sum of various health impacts.
Economic loss of PM10-related health impacts from 2008 to 2012.
| Health Endpoints | Economic Loss ($) | ||||
|---|---|---|---|---|---|
| 2008 | 2009 | 2010 | 2011 | 2012 | |
| Individual mortality | 1.35E + 10 | 1.41E + 10 | 1.71E + 10 | 1.77E + 10 | 1.79E + 10 |
| Chronic bronchitis | 9.82E + 09 | 1.03E + 10 | 1.24E + 10 | 1.28E + 10 | 1.30E + 10 |
| Respiratory hospitalization | 6.12E + 07 | 7.06E + 07 | 7.96E + 07 | 7.70E + 07 | 7.49E + 07 |
| Cardiovascular hospitalization | 1.87E + 07 | 2.15E + 07 | 2.43E + 07 | 2.35E + 07 | 2.29E + 07 |
| Outpatient visits to internal medicine | 5.15E + 05 | 5.54E + 05 | 6.37E + 05 | 6.26E + 05 | 6.23E + 05 |
| Outpatient visits to pediatrics | 2.17E + 05 | 2.33E + 05 | 2.68E + 05 | 2.63E + 05 | 2.62E + 05 |
| Acute bronchitis | 1.04E + 07 | 1.15E + 07 | 1.39E + 07 | 1.40E + 07 | 1.42E + 07 |
| Asthma attacks | 1.20E + 08 | 1.38E + 08 | 1.66E + 08 | 1.67E + 08 | 1.71E + 08 |
| Total loss | 2.36E + 10 | 2.46E + 10 | 2.98E + 10 | 3.08E + 10 | 3.12E + 10 |
Figure 5Health economic loss in different districts and counties in 2012.
Figure 6Health economic loss of per km2 and per thousand people in different districts.
Figure 7PM10 health economic losses of Beijing from 2008 to 2012.